Position in NBIX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$372,559
-$13,501 QoQ
Shares Held
2,828
+3.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vontobel Holding Ltd. holds $113,933,883 across 18 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
766,101 | $90,560,795 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
497,461 | $14,983,524 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
162,101 | $3,365,216 | |
| 4 | ALKS |
Alkermes plc.
|
32,101 | $1,135,090 | |
| 5 | LQDA |
Liquidia Corp
|
17,610 | $664,601 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
813 | $482,091 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
17,843 | $426,982 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,828 | $372,559 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $372,559 | 2,828 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $386,060 | 2,722 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $383,937 | 2,735 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $516,710 | 4,111 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $1,099,695 | 9,943 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $1,152,332 | 8,442 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $1,681,058 | 14,590 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $1,782,962 | 12,951 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,124,047 | 8,150 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $802,285 | 6,089 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $951,524 | 8,458 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $915,463 | 9,708 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $1,042,868 | 10,303 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $384,715 | 3,221 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $622,920 | 5,865 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $478,236 | 4,906 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $3,758,906 | 40,095 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,862,922 | 21,873 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,724,749 | 17,983 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $1,884,990 | 19,369 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $1,555,513 | 15,995 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $1,807,059 | 18,853 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||